AU2018903891A0 - Methods and compositions for the treatment of mucosal lesions - Google Patents

Methods and compositions for the treatment of mucosal lesions

Info

Publication number
AU2018903891A0
AU2018903891A0 AU2018903891A AU2018903891A AU2018903891A0 AU 2018903891 A0 AU2018903891 A0 AU 2018903891A0 AU 2018903891 A AU2018903891 A AU 2018903891A AU 2018903891 A AU2018903891 A AU 2018903891A AU 2018903891 A0 AU2018903891 A0 AU 2018903891A0
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
mucosal lesions
mucosal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018903891A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ABREGEN Pty Ltd
Original Assignee
ABREGEN Pty Ltd
Filing date
Publication date
Application filed by ABREGEN Pty Ltd filed Critical ABREGEN Pty Ltd
Publication of AU2018903891A0 publication Critical patent/AU2018903891A0/en
Priority to PCT/AU2019/051117 priority Critical patent/WO2020077397A1/en
Abandoned legal-status Critical Current

Links

AU2018903891A 2018-10-15 2018-10-15 Methods and compositions for the treatment of mucosal lesions Abandoned AU2018903891A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2019/051117 WO2020077397A1 (en) 2018-10-15 2019-10-15 Methods and compositions for the treatment of mucosal lesions

Publications (1)

Publication Number Publication Date
AU2018903891A0 true AU2018903891A0 (en) 2018-11-01

Family

ID=

Similar Documents

Publication Publication Date Title
EP3894392A4 (en) Compositions and methods for the treatment of cancer
EP3716767A4 (en) Methods and compositions for the treatment of rare diseases
EP3735325A4 (en) Surface treatment compositions and methods
EP3826666A4 (en) Compositions and methods for treating nrp2-associated diseases
EP3890748A4 (en) Compositions and methods for the treatment of liver disorders
EP3402533A4 (en) Methods and compositions for the treatment of neurologic disease
EP3775263A4 (en) Compositions and methods for the treatment of acne
EP3790563A4 (en) Compositions for the treatment of skin conditions
EP3784260A4 (en) Compositions for the treatment of skin conditions
EP3675871A4 (en) Compositions and methods for the treatment of fibrotic diseases
EP3740576A4 (en) Therapeutic compositions and methods of making and using the same
EP3969597A4 (en) Compositions and methods for the treatment of atpase-mediated diseases
EP3761970A4 (en) Compositions and methods for the treatment of neurological diseases
EP4017924A4 (en) Surface treatment compositions and methods
EP3452044A4 (en) Compositions and methods for the treatment of cancer
EP3813872A4 (en) Compositions for the treatment of skin conditions
EP3600277A4 (en) Compositions for the treatment of drug-resistant tumors and methods of use thereof
EP4058041C0 (en) Compositions for the treatment of epithelial lesions
EP3500274A4 (en) Methods and compositions for the treatment of warts
EP3538079A4 (en) Compositions and methods for the treatment of oral infectious diseases
EP3830196A4 (en) Surface treatment compositions and methods
EP3820477A4 (en) Compounds, compositions, and methods for the treatment of disease
EP3681498A4 (en) Methods and compositions for the treatment of cancer
EP3661953A4 (en) Methods and compositions for the treatment of cancer
EP3554494A4 (en) Compositions and methods for the treatment of inflammation